[1] J. Dudek, P. Rehling, M. van der Laan, Mitochondrial protein import: common principles and physiological networks, Biochim. Biophys. Acta - Mol. Cell Res. 1833 (2013) 274e285, http://dx.doi.org/10.1016/j.bbamcr.2012.05.028.
[2] J. Asin-Cayuela, C.M. Gustafsson, Mitochondrial transcription and its regula- tion in mammalian cells, Trends Biochem. Sci. 32 (2007) 111e117, http:// dx.doi.org/10.1016/j.tibs.2007.01.003.
[3] N.J. Lake, M.J. Bird, P. Isohanni, A. Paetau, Leigh syndrome: neuropathology and pathogenesis, J. Neuropathol. Exp. Neurol. 74 (2015) 482e492, http:// dx.doi.org/10.1097/NEN.0000000000000195.
[4] S. DiMauro, Mitochondrial diseases, Biochim. Biophys. Acta - Bioenerg. 1658 (2004) 80e88, http://dx.doi.org/10.1016/j.bbabio.2004.03.014.
[5] S. Parikh, A. Goldstein, A. Karaa, M.K. Koenig, I. Anselm, C. Brunel-Guitton, J. Christodoulou, B.H. Cohen, D. Dimmock, G.M. Enns, M.J. Falk, A. Feigenbaum, R.E. Frye, J. Ganesh, D. Griesemer, R. Haas, R. Horvath, M. Korson, M.C. Kruer, M. Mancuso, S. McCormack, M.J. Raboisson, T. Reimschisel, R. Salvarinova, R.P. Saneto, F. Scaglia, J. Shoffner, P.W. Stacpoole, C.M. Sue, M. Tarnopolsky, C. Van Karnebeek, L.A. Wolfe, Z.Z. Cunningham, S. Rahman, P.F. Chinnery, Patient care standards for primary mitochondrial disease: a consensus state- ment from the Mitochondrial Medicine Society, Genet. Med. (2017), http:// dx.doi.org/10.1038/gim.2017.107.
[6] S.S. Gandhi, C. Muraresku, E.M. McCormick, M.J. Falk, S.E. McCormack, Risk factors for poor bone health in primary mitochondrial disease, J. Inherit. Metab. Dis. (2017) 1e11, http://dx.doi.org/10.1007/s10545-017-0046-2.
[7] A. Trifunovic, A. Wredenberg, M. Falkenberg, J.N. Spelbrink, A.T. Rovio, C.E. Bruder, M. Bohlooly-Y, S. Gidlof, A. Oldfors, R. Wibom, J. Tornell, H.T. Jacobs, N.-G. Larsson, Premature ageing in mice expressing defective mitochondrial DNA polymerase, Nature 429 (2004) 417e423. http://dx.doi. org/10.1038/nature02517.
[8] T. Mito, H. Ishizaki, M. Suzuki, H. Morishima, A. Ota, K. Ishikawa, K. Nakada, A. Maeno, T. Shiroishi, J.I. Hayashi, Transmitochondrial mito-miceD and mtDNA mutator mice, but not aged mice, share the same spectrum of musculoskeletal disorders, Biochem. Biophys. Res. Commun. 456 (2015) 933e937, http://dx.doi.org/10.1016/j.bbrc.2014.12.009.
[9] D. Leigh, Subacute necrotizing encephalomyelopathy in an infant, J. Neurol. Neurosurg. Psychiatry 14 (1951) 216e221, http://dx.doi.org/10.1136/ jnnp.14.3.216.
[10] H. Kato, T.T.M. Pham, H. Yamaza, K. Masuda, Y. Hirofuji, X. Han, H. Sato, T. Taguchi, K. Nonaka, Mitochondria regulate the differentiation of stem cells from human exfoliated deciduous teeth, Cell Struct. Funct 116 (2017) 105e116, http://dx.doi.org/10.1247/csf.17012.
[11] S. Nishiyama, K. Kiwaki, I. Takeaki, Y. Seino, Bone mineral density of the lumber spine and total body mass in Japanese children and adolescents, J. Jpn. Pediatr. Soc. 103 (1999) 1131e1138.
[12] H. Jung, O. Akkus, Activation of intracellular calcium signaling in osteoblasts colocalizes with the formation of post-yield diffuse microdamage in bone matrix, Bonekey Rep. 5 (2016) 1e7, http://dx.doi.org/10.1038/ bonekey.2016.5.
[13] S. Boonrungsiman, The role of intracellular calcium phosphate in osteoblast- mediated bone apatite formation, Proc. Natl. Acad. Sci. 109 (2012) 14170e14175, http://dx.doi.org/10.1073/pnas.1208916109/-/DCSupple- mental. www.pnas.org/cgi/doi/10.1073/pnas.1208916109.
[14] X. Xu, S. Duan, F. Yi, A. Ocampo, G.H. Liu, J.C. Izpisua Belmonte, Mitochondrial regulation in pluripotent stem cells, Cell Metab. 18 (2013) 325e332, http:// dx.doi.org/10.1016/j.cmet.2013.06.005.
[15] C.T. Chen, Y.R. Shih, T.K. Kuo, O.K. Lee, Y.H. Wei, Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differ- entiation of human mesenchymal stem cells, Stem Cells 26 (2008) 960e968, http://dx.doi.org/10.1634/stemcells.2007-0509.
[16] A. Sudo, S. Honzawa, I. Nonaka, Y. Goto, Leigh syndrome caused by mito- chondrial DNA G13513A mutation: frequency and clinical features in Japan, (2004) 92e96. http://dx.doi.org/10.1007/s10038-003-0116-1.
[17] A. Diehlmann, S. Bork, R. Saffrich, R.W. Veh, W. Wagner, C. Derst, KATP channels in mesenchymal stromal stem cells: strong up-regulation of Kir6.2 subunits upon osteogenic differentiation, Tissue Cell. 43 (2011) 331e336, http://dx.doi.org/10.1016/j.tice.2011.06.004.
[18] Y. Liu, et al., Hydrogen sulfide maintains mesenchymal stem cell function and bone homeostasis via regulation of Ca2+ channel sulfhydration, Cell Stem Cell. 15 (2014) 66e78.
[19] J.H. Kim, X. Liu, J. Wang, X. Chen, H. Zhang, S.H. Kim, J. Cui, R. Li, W. Zhang, Y. Kong, J. Zhang, W. Shui, J. Lamplot, M.R. Rogers, C. Zhao, N. Wang, P. Rajan, J. Tomal, J. Statz, N. Wu, H.H. Luu, R.C. Haydon, T.-C. He, Wnt signaling in bone formation and its therapeutic potential for bone diseases, Ther. Adv. Muscu- loskelet. Dis. 5 (2013) 13e31, http://dx.doi.org/10.1177/1759720X12466608.
[20] V. Krishnan, H.U. Bryant, O.A. MacDougaldyrant, Regulation of bone mass by Wnt signaling, J. Clin. Invest 116 (2006) 1202e1209, http://dx.doi.org/ 10.1172/JCI28551.1202.
[21] H. Rottenberg, A. Scarpa, Calcium uptake and membrane potential in mito- chondria, Biochemistry 13 (1974) 4811e4817.
[22] E.E. Golub, Biomineralization and matrix vesicles in biology and pathology, Semin. Immunopathol. 33 (2011) 409e417, http://dx.doi.org/10.1007/ s00281-010-0230-z.
[23] R.E. Wuthier, G.F. Lipscomb, Matrix vesicles: structure, composition, forma- tion and function in calcification, Front. Biosci. (Landmark Ed.) 16 (2011) 2812e2902.